Search research articles
Contact Us
Filters
Showing results (361-370 of 390) with videos related to
Page
of 39
Sort By:
Schizophrenia Bulletin
|
April 6, 2023
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)
Andreas Bechdolf, Hendrik Müller, Martin Hellmich, et al.
JAMA Network Open
|
May 29, 2020
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial
Franziska Maier, Annika Spottke, Jan-Philipp Bach, et al.
European Journal of Heart Failure
|
August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial
Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
BMJ Open
|
January 26, 2022
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol
Heidrun Golla, Kim Dillen, Martin Hellmich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography
Thomas Zander, Matthias Scheffler, Lucia Nogova, et al.
Circulation
|
April 12, 2024
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
Felix Gerhardt, Eva Fiessler, Karen M Olsson, et al.
Circulation
|
February 12, 2025
MYSTERY-HF: Myeloperoxidase Inhibition in Patients With Heart Failure and Reduced Ejection Fraction: A Phase II Randomized Controlled Trial
Simon Braumann, Sascha Macherey-Meyer, Amin Polzin, et al.
European Journal of Heart Failure
|
August 30, 2024
Inhibition of myeloperoxidase to treat left ventricular dysfunction in non-ischaemic cardiomyopathy
Simon Geissen, Simon Braumann, Joana Adler, et al.
Trials
|
November 13, 2024
PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial
Rouvier Al-Monajjed, Peter Albers, Johanna Droop, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 2, 2023
Apathy in patients with Alzheimer's disease is a cost-driving factor
Christopher Kruse, Franziska Maier, Annika Spottke, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 390) with videos related to
Sort By:
Page
of 39
Schizophrenia Bulletin
|
April 6, 2023
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)
Andreas Bechdolf, Hendrik Müller, Martin Hellmich, et al.
JAMA Network Open
|
May 29, 2020
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial
Franziska Maier, Annika Spottke, Jan-Philipp Bach, et al.
European Journal of Heart Failure
|
August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial
Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
BMJ Open
|
January 26, 2022
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol
Heidrun Golla, Kim Dillen, Martin Hellmich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography
Thomas Zander, Matthias Scheffler, Lucia Nogova, et al.
Circulation
|
April 12, 2024
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
Felix Gerhardt, Eva Fiessler, Karen M Olsson, et al.
Circulation
|
February 12, 2025
MYSTERY-HF: Myeloperoxidase Inhibition in Patients With Heart Failure and Reduced Ejection Fraction: A Phase II Randomized Controlled Trial
Simon Braumann, Sascha Macherey-Meyer, Amin Polzin, et al.
European Journal of Heart Failure
|
August 30, 2024
Inhibition of myeloperoxidase to treat left ventricular dysfunction in non-ischaemic cardiomyopathy
Simon Geissen, Simon Braumann, Joana Adler, et al.
Trials
|
November 13, 2024
PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial
Rouvier Al-Monajjed, Peter Albers, Johanna Droop, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 2, 2023
Apathy in patients with Alzheimer's disease is a cost-driving factor
Christopher Kruse, Franziska Maier, Annika Spottke, et al.
Page
of 39